Monitoring of endothelial leucocyte adhesion molecule-1 in anti-neutrophil-cytoplasmic-antibody-positive vasculitis

American Journal of Nephrology

Volumn 16, Issue 2, 1996, Pages 106-113

  Yagoob, Muhammad ^a   West, David C ^a   McDicken, Ion ^a   Bell, Gordon M ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Anti neutrophil cytoplasmic; Antibody serology Monitoring; Soluble ELAM 1; Vasculitis

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIALYSIS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTICEMIA; VASCULITIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; C-REACTIVE PROTEIN; E-SELECTIN; FEMALE; GLOMERULONEPHRITIS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; VON WILLEBRAND FACTOR; WEGENER GRANULOMATOSIS;

EID: 0030053795     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000168980     Document Type: Article

References (35)

1. Parfrey PS, Hutchinson TA, Jothy S, Cramer BC, Martin J, Hanley JA, Seely JF: The spectrum of diseases associated with necrotizing glomerulonephritis and its prognosis. Am J Kidney Dis 1985;VI(6):387-396.
2. Balow JE: Renal vasculitis. Kidney Int 1985; 27:954-964.
3. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, Van Es LA, Van Der Giessen M, van Der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i: 425-429.
4. Falk RJ. Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988:318: 1651-57.
5. DeRemee RA: Anti-neutrophil cytoplasmic autoantibody diseases: A pulmonologist’s perspective. Am J Kidney Dis 1991:28:180-183.
6. Jennette JC, Wilkman AS, Falf RJ: Anti-neutrophil cytoplasmic auto-antibody associated glomerulonephritis and vasculitis. Am J Pathol 1989;135:921-930.
7. Niles JL, McCluskev RT. Ahmad MF, Amaout MA: Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989;74:1888-1893.
8. Ludemann J, Utecht B, Gross WL: Anti-neu-trophil cytoplasmic antibodies in Wegener’s granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990;171:357-362.
9. Jenne DE, Tschopp J, Ludemann J, Utecht B. Gross WL: Wegener’s autoantigen decoded. Nature 1990:346:520.
10. Goldscheding R, Tervaert JW, Van der School CF, Kallenberg, CGM, Vom Dem Borne AEGKR: ANCA, anti-myeloperoxidase and anti-clastase: Three members of a novel class of autoantibodies against myeloid lysosomal enzymes. Acta Pathol Microbiol Immunol Scand 1989;97(suppl):48-49.
11. Falk RJ, Terrell R, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals. Proc Natl Acad Sei USA 1990;87: 4115-4119.
12. Even BH, Jennette JC, Falk RJ: The pathogenic role of anti-neutrophil cytoplasmic antibodies. Am J Kidney Dis 1991;2:188-195.
13. Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener’s granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
14. Bradley JD, Brandt KD, Katz BP: Infectious complications of cyclophosphamide treatment for vasculitis. Arthritis Rheum 1989;32:45-53.
15. Stilvell TJ, Benson RC, DeRemee RA, McDonald TJ, Weiland LH: Cyclophosphamide-induced bladder toxicity in Wegener’s granulomatosis. Arthritis Rheum 1988;31: 465-470.
16. Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambus JL, Velosa J, Keane WF, Meijers A, Van Der Giessen M, The TH, Van Der Hem GK, Kallenberg CGM: Association between active Wegener’s granulomatosis and anticyto-plasmic antibody. Arch Intern Med 1989,149: 2461-2465.
17. Cohen Tervaert JW, Huitema MG, Hene RJ, Sluitcr WJ, The TH, VanDer Hem GK, Kallenberg CGM: Prevention of relapses in Wegener’s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titer. Lancet 1990;336:709-711.
18. Kerr GS, Flcishcr TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS: Limited prognostic value of changes in anticytoplasmic antibody titer in patients with Wegener’s granulomatosis. Arthritis Rheum 1993:36:365-371.
19. Hind CRK, Savage CO, Winearls CG, Pepys MB: Objective monitoring of disease activity in polyarteritis by measurement of serum C-reac-tive protein concentration. Br J Med 1984;288: 1027-30.
20. Tuddenham EGD, Lazarchick J, Hoyer LW: Synthesis and release of factor VIII by cultured endothelial cells. Br J Haematol 1981:47:617- 626.
21. Ambruso DR, Durante DP, McIntosh RM, Hathaway WE: Factor VIII and renal disease. Ann Intern Med 1977;87:636.
22. Yaqoob M. Patrick AW. McClelland P, Stevenson A, Mason H, White MC, Bell GM: Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin dependent diabetes mellitus. Clin Sei 1993;85:557-562.
23. Woolf AD, Wakerley G, Wallington TB, Scott DGI, Dieppe PA: Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis 1987;46:441-447.
24. Belch JJF, Zoma AA, Richards IM, McLaughlin K, Forbes CD, Sturrock RA: Vascular damage and factor VIII related antigen in the rheumatic diseases. Rheumatol Int 1987;7:107- 111.
25. Meucci P. Peak IR. Bloom AL: Factor VIII related activities in normal haemophiliacs and von Willebrand’s disease platelet fractions. Thromb Haemost 1978;40:288-301.
26. Cosio FG, Orosz CG: Adhesion molecules and the kidney in health and disease. J Nephrol 1993;6:22-32.
27. Bevilacqua MP. Steingclin S, Gimbrone MA, Seed B: Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989;243:1160-1165.
28. Gearing AJH, Hemingway I, Pigot R, Hughes J, Rees AJ, Cashman SJ: Soluble forms of vascular adhesion molecules, E-se!ectin. ICAM-1 and VCAM-1: Pathological significance. Ann NY Acad Sei 1992;667:324-331.
29. Rasmussen N, Sjolin C, Isaksson B, Bygren P, Wieslander J: An ELISA for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). J Immunol Methods 1990; 127:139- 145.
30. Stevens ME. McConnell M. Bone JM: Aggressive treatment with pulse methylprednisolone or plasma exchange is justified in rapidly progressive crescentic glomerulonephritis. Proc Eur Dial Transplant Assoc 1983:19:724-731.
31. Hagen EC. Ballicux BEPB, Daha MR, Van Es LA, van der Woude FJ: Fundamental and clinical aspects of antineutrophil cytoplasmic antibodies. Autoimmunity 1992; 11:199-207.
32. Esnault VLM, Short AK, Audrain MAP, Jones SJ, Martin SJ, Skehel MJ, Lockwood CM: Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays. Kidney Int 1994;46: 153-160.
33. Gross WL, Hauschild S, Mistry N: The clinical relevance of ANCA in vasculitis. Clin Exp Immunol 1993;93(suppl 1):7-11.
34. Lo SK, Lee S, Ramos RA, Lobb R, Rosa M, Chi-Rosso G, Wright SD: Endothelial-leuko-cytc adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 on human neutrophils. J Exp Med 1991; 173:1493-1500.
35. Carson CW, Beall LD. Hunder GG, Johnson CM, Newman W: Scrum ELAM-1 is increased in vasculitis, scleroderma and systemic lupus ervthematosis. J Rheumatol 1993:20:809-814.